Roberts Sigrid C, Tancer Michael J, Polinsky Michelle R, Gibson K Michael, Heby Olle, Ullman Buddy
Department of Biochemistry and Molecular Biology, Oregon Health & Science University, Portland 97239-3098, USA.
J Biol Chem. 2004 May 28;279(22):23668-78. doi: 10.1074/jbc.M402042200. Epub 2004 Mar 15.
The polyamine pathway of protozoan parasites has been successfully targeted in anti-parasitic therapies and is significantly different from that of the mammalian host. To gain knowledge into the metabolic routes by which parasites synthesize polyamines and their precursors, the arginase gene was cloned from Leishmania mexicana, and Deltaarg null mutants were created by double targeted gene replacement and characterized. The ARG sequence exhibited significant homology to ARG proteins from other organisms and predicted a peroxisomal targeting signal (PTS-1) that steers proteins to the glycosome, an organelle unique to Leishmania and related parasites. ARG was subsequently demonstrated to be present in the glycosome, whereas the polyamine biosynthetic enzymes, in contrast, were shown to be cytosolic. The Deltaarg knockouts expressed no ARG activity, lacked an intracellular ornithine pool, and were auxotrophic for ornithine or polyamines. The ability of the Deltaarg null mutants to proliferate could be restored by pharmacological supplementation, either with low putrescine or high ornithine or spermidine concentrations, or by complementation with an arginase episome. Transfection of an arg construct lacking the PTS-1 directed the synthesis of an arg that mislocalized to the cytosol and notably also complemented the genetic lesion and restored polyamine prototrophy to the Deltaarg parasites. This molecular, biochemical, and genetic dissection of ARG function in L. mexicana promastigotes establishes: (i) that the enzyme is essential for parasite viability; (ii) that Leishmania, unlike mammalian cells, expresses only one ARG activity; (iii) that the sole vital function of ARG is to provide polyamine precursors for the parasite; and (iv) that ARG is present in the glycosome, but this subcellular milieu is not essential for its role in polyamine biosynthesis.
原生动物寄生虫的多胺途径已成功成为抗寄生虫治疗的靶点,且与哺乳动物宿主的多胺途径有显著差异。为了解寄生虫合成多胺及其前体的代谢途径,从墨西哥利什曼原虫中克隆了精氨酸酶基因,并通过双靶向基因替换创建了Δarg基因敲除突变体并对其进行了表征。ARG序列与其他生物的ARG蛋白具有显著同源性,并预测了一个过氧化物酶体靶向信号(PTS-1),该信号可将蛋白质导向糖体,糖体是利什曼原虫及相关寄生虫特有的一种细胞器。随后证明ARG存在于糖体中,而多胺生物合成酶则存在于胞质溶胶中。Δarg基因敲除突变体不表达ARG活性,缺乏细胞内鸟氨酸池,对鸟氨酸或多胺营养缺陷。通过药理学补充,即低腐胺、高鸟氨酸或亚精胺浓度,或用精氨酸酶附加体进行互补,可以恢复Δarg基因敲除突变体的增殖能力。转染缺乏PTS-1的arg构建体可指导合成定位于胞质溶胶的错误定位的arg,并且显著地也补充了遗传损伤并恢复了Δarg寄生虫的多胺原养型。对墨西哥利什曼原虫前鞭毛体中ARG功能的这种分子、生化和遗传学剖析确立了:(i)该酶对寄生虫的生存能力至关重要;(ii)与哺乳动物细胞不同,利什曼原虫仅表达一种ARG活性;(iii)ARG的唯一重要功能是为寄生虫提供多胺前体;(iv)ARG存在于糖体中,但这种亚细胞环境对其在多胺生物合成中的作用并非必不可少。